Spinal procedures shifting from inpatient to outpatient settings, evolving payer-provider relationships and a minimally invasive surgery boom are some of the key trends dominating the spine industry this year.
The Latest
Jason Toy, MD, of Austin-based Orthopedic Associates of Central Texas, debuted a new lateral interbody system made of 3D-printed titanium.
Centene has created a positive coverage policy for minimally invasive sacroiliac joint fusion, according to a July 14 news release.
From FDA clearances to strengthened partnerships, here are seven updates from spine and orthopedic device companies in the last week:
Standardizing biologics research in sports medicine is one of the most important issues Alexis Colvin, MD, of New York City-based Mount Sinai is paying attention to.
New partnership models with aligned goals, an increased push toward orthopedic Centers of Excellence and heightened calls for a single-payer system are among the major trends these four spine surgeons see over the next five years.
The FDA has granted breakthrough device designation for Spino Modulation's MIScoli system, a vertebral body tethering system to treat adolescent idiopathic scoliosis.
CMS' Open Payments program requires drug and devicemakers to report payments or transfers of value to physicians, teaching hospitals and other providers to increase the transparency of these relationships.
Since launching its initial public offering in February, orthobiologics company Bioventus marked several notable achievements, including a multimillion-dollar acquisition.
Des Plaines-based Illinois Bone & Joint Institute launched Epic as its new electronic medical record system July 12.